MLTX MoonLake Corp: Rasio rega marang prakiraan pendapatan

MoonLake Immunotherapeutics - logo grafis emiten MLTX

MoonLake Immunotherapeutics develops liver therapies in the US and Switzerland. The projected P/S value confirms the market valuation, where the metric determines this level. An agile staff of scientists motivated by stock options is driving the company's development. However, success depends on the clinical trial results for sonelokimab and the ability to withstand the expansion of pharmaceutical behemoths.

MoonLake - Rasio kapitalisasi marang dodolan sing dikarepake MLTX (periode 04.07.2022 - 15.11.2026)

Ringkesan rincian data analitis moonlaketx.com (MLTX)

- data kapitalisasi saham perusahaan:
Analisis kabeh metrik perusahaan:MLTX (moonlaketx.com)
Produk asli MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) seeks to mitigate the risks of single-product dependence on sonelokimab by scaling the drug's application across rheumatology and dermatology. The forward P/S ratio compares current market capitalization with projected revenues, allowing this chart's price action to assess whether the market valuation is fair relative to expected revenue and to avoid overpaying for speculative investor optimism.

Analisis pesaing

Rasio rega marang prakiraan pendapatan ascendispharma.com ASND|Madrigal Corp (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan soleno.life (SLNO)|Multiplikator forward rega marang pendapatan Amicus Therapeutics FOLD|Rega forward marang dodolan 89bio Inc|Multiplikator Forward P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake MiMedx Corp MDXG|RZLT (Rezolute Corp) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Altimmune Inc (ALT)|Multiplikator forward rega marang pendapatan AARD (Aardvark Therapeutics Corp)|Multiplikator forward rega marang pendapatan Sagimet SGMT|Multiplikator Forward P/S BIOA (BioAge Labs)|Multiplikator Forward P/S Biomea Fusion BMEA|QNCX: Multiplikator forward rega marang pendapatan|GUTS: Rasio rega marang prakiraan pendapatan|vTv Therapeutics Inc (VTVT) - Rasio rega marang prakiraan pendapatan|ATPC: Rasio rega marang pendapatan sing dikarepake|PLUR (pluri-biotech.com) - Multiplikator Forward P/S|SYBX: Rega forward marang dodolan|Multiplikator Forward P/S LPCN|Rasio kapitalisasi marang dodolan sing dikarepake Matinas BioPharma Holdings, Inc.|Rasio rega marang prakiraan pendapatan Spruce Biosciences Inc. SPRB|GLTO - Multiplikator forward rega marang pendapatan|CTCX - Rasio rega marang prakiraan pendapatan|LUMO - Multiplikator Forward P/S|ONVO: Multiplikator Forward P/S|RDUS (Radius Recycling) - Rasio rega marang prakiraan pendapatan